Gabi Tamayo ‘24 pitched Zoetis (NYSE:ZTS) on October 2, 2023. Zoetis is the world’s leading animal health pharmaceutical company. Zoetis has over 300 products and product lines within the companion animal and livestock market, selling in over 100 countries. With a market capitalization of $80 billion, Zoetis sits as the 19th largest stock in the healthcare industry. Gabi’s investment thesis focused on the exponentially growing demand for animal health and key advantages to animal health pharmaceuticals compared to human health pharmaceuticals. The main drivers behind companion animal health care growth are the humanization of pets by younger and wealthier individuals and the unmet need for speciality care. The animal health pharmaceuticals industry displays (1) lower drug production costs, (2) faster timeline to approval, and (3) lower generics utilization rates. As the industry market leader, the company is well positioned to be on the receiving end of significant animal health growth and continue to outperform the healthcare sector. The company displays excellent financial health with high margins, profitability, and liquidity. SMIF voted to invest $55,000, funded by the sale of AMGN.